INS and inflammatory bowel disease: In line with our results, FNDC4 has been previously described as an anti-inflammatory factor increased in inflamed sites of the intestine of patients with inflammatory bowel disease [4] as well as an adipokine with insulin-sensitizing [27] and anti-lipogenic properties [22].